Enrollment is now CLOSED for the Metastatic Prostate Cancer Project (MPCproject).

Thank you to everyone who has participated. The data generated through the project will continue to impact discoveries, ultimately leading to a better understanding and faster advances in the treatment of prostate cancer.

Count Me In remains committed to elevating patient centered research, revolutionizing the understanding of rare cancers and rare diseases, accelerating treatment discovery, and driving medical progress.

Metastatic Prostate Cancer Project Timeline

2018

MPCproject launched through collaboration with patients and advocates
Poster presentation at GU ASCO: The Metastatic Prostate Cancer (MPCproject): transational genomics through direct patient engagement

2019

First data release from 19 patients shared on cBioPortal
GU Onc Uro Today podcast with Dr. Chuck Ryan featured Dr. Eli Van Allen discussing the project: Count Me In! The Metastatic Prostate Cancer Project - Eliezer Van Allen

2020

Data shared with researchers through additional repositories: the National Institute of Health’s (NIH) database of Genotypes and Phenotypes (dbGaP) and the National Cancer Institute’s (NCI) Genomic Data Commons (GDC)
First request for serial blood samples from existing participants

2021

Over 750 individuals with advanced or metastatic prostate cancer have fully enrolled in the project
Preprint of publication shared on bioRx A patient driven clinicogenomic partnership through the Metastatic Prostate Cancer Project | bioRxiv

2022

Publication printed in Cell Genomics: A patient-driven clinicogenomic partnership for metastatic prostate cancer

2025

Over 900 metastatic prostate cancer patients have fully enrolled, including nearly 100 serial blood sample participants. Data generated by the project will serve as a catalyst for ongoing research for years to come
Analysis and publication of final data set to come, including patient reported data, abstracted medical record data, and sequenced genomic data from ~370 patients
Final data set also includes data on >175 serial blood samples from >75 participants

Questions? Please reach out to us at any time at info@joincountmein.org.

Enrollment is now CLOSED for the Metastatic Prostate Cancer Project (MPCproject).

Metastatic Prostate Cancer Project Timeline

2018

MPCproject launched through collaboration with patients and advocates

Poster presentation at GU ASCO: The Metastatic Prostate Cancer (MPCproject): transational genomics through direct patient engagement

2019

First data release from 19 patients shared on cBioPortal

GU Onc Uro Today podcast with Dr. Chuck Ryan featured Dr. Eli Van Allen discussing the project: Count Me In! The Metastatic Prostate Cancer Project - Eliezer Van Allen

2020

Data shared with researchers through additional repositories: the National Institute of Health’s (NIH) database of Genotypes and Phenotypes (dbGaP) and the National Cancer Institute’s (NCI) Genomic Data Commons (GDC)

First request for serial blood samples from existing participants

2021

Over 750 individuals with advanced or metastatic prostate cancer have fully enrolled in the project

Preprint of publication shared on bioRx A patient driven clinicogenomic partnership through the Metastatic Prostate Cancer Project | bioRxiv

2022

Publication printed in Cell Genomics: A patient-driven clinicogenomic partnership for metastatic prostate cancer

2025

Over 900 metastatic prostate cancer patients have fully enrolled, including nearly 100 serial blood sample participants. Data generated by the project will serve as a catalyst for ongoing research for years to come

Analysis and publication of final data set to come, including patient reported data, abstracted medical record data, and sequenced genomic data from ~370 patients

Final data set also includes data on >175 serial blood samples from >75 participants